Gene · 3838
Papers1,821
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,821
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Usp22 Deficiency Leads to Downregulation of PD-L1 and Pathological Activation of CD8+ T Cells and Causes Immunopathology in Response to Acute LCMV Infection. | Vaccines (Basel) | 2023 | 37896966 | PubTator, text mining | PubMed |
| Mechanistic Insights into the Anti-Proliferative Action of Gut Microbial Metabolites against Breast Adenocarcinoma Cells. | Int J Mol Sci | 2023 | 37894734 | PubTator, text mining | PubMed |
| TP53-PTEN-NF1 depletion in human brain organoids produces a glioma phenotype in vitro. | Front Oncol | 2023 | 37881491 | PubTator, text mining | PubMed |
| Parkin regulates IGF2BP3 through ubiquitination in the tumourigenesis of cervical cancer. | Clin Transl Med | 2023 | 37877353 | PubTator, text mining | PubMed |
| Radiotherapy remodels the tumor microenvironment for enhancing immunotherapeutic sensitivity. | Cell Death Dis | 2023 | 37833255 | PubTator, text mining | PubMed |
| Karyopherins in the Remodeling of Extracellular Matrix: Implications in Tendon Injury. | J Orthop Sports Med | 2023 | 37829147 | PubTator, text mining | PubMed |
| USP1 promotes cholangiocarcinoma progression by deubiquitinating PARP1 to prevent its proteasomal degradation. | Cell Death Dis | 2023 | 37821462 | PubTator, text mining | PubMed |
| Integrated single-cell and spatial transcriptomics reveals heterogeneity of fibroblast and pivotal genes in psoriasis. | Sci Rep | 2023 | 37816883 | PubTator, text mining | PubMed |
| Nuclear ERK1/2 signaling potentiation enhances neuroprotection and cognition via Importinα1/KPNA2. | EMBO Mol Med | 2023 | 37792911 | PubTator, text mining | PubMed |
| What do we know about the function of SARS-CoV-2 proteins? | Front Immunol | 2023 | 37790934 | PubTator, text mining | PubMed |
| The pivotal role of EMT-related noncoding RNAs regulatory axes in hepatocellular carcinoma. | Front Pharmacol | 2023 | 37767397 | PubTator, text mining | PubMed |
| Potential of Dietary HDAC2i in Breast Cancer Patients Receiving PD-1/PD-L1 Inhibitors. | Nutrients | 2023 | 37764768 | PubTator, text mining | PubMed |
| Evaluation of Dimercaptosuccinic Acid-Coated Iron Nanoparticles Immunotargeted to Amyloid Beta as MRI Contrast Agents for the Diagnosis of Alzheimer's Disease. | Cells | 2023 | 37759500 | PubTator, text mining | PubMed |
| S100A2 induces epithelial-mesenchymal transition and metastasis in pancreatic cancer by coordinating transforming growth factor β signaling in SMAD4-dependent manner. | Cell Death Discov | 2023 | 37758734 | PubTator, text mining | PubMed |
| Identification of endoplasmic reticulum stress-related biomarkers of diabetes nephropathy based on bioinformatics and machine learning. | Front Endocrinol (Lausanne) | 2023 | 37745718 | PubTator, text mining | PubMed |
| Identification of MIR600HG/hsa-miR-342-3p/ANLN network as a potential prognosis biomarker associated with lmmune infiltrates in pancreatic cancer. | Sci Rep | 2023 | 37741887 | PubTator, text mining | PubMed |
| Aedes aegypti Argonaute 2 controls arbovirus infection and host mortality. | Nat Commun | 2023 | 37723154 | PubTator, text mining | PubMed |
| Unraveling the impact of disrupted nucleocytoplasmic transport systems in C9orf72-associated ALS. | Front Cell Neurosci | 2023 | 37720544 | PubTator, text mining | PubMed |
| Enhancing HCC Treatment: innovatively combining HDAC2 inhibitor with PD-1/PD-L1 inhibition. | Cancer Cell Int | 2023 | 37716965 | PubTator, text mining | PubMed |
| An Early Neoplasia Index (ENI10), Based on Molecular Identity of CD10 Cells and Associated Stemness Biomarkers, is a Predictor of Patient Outcome in Many Cancers. | Cancer Res Commun | 2023 | 37707389 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3838/papers?page=9